Rituximab is effective for extensive steroid-refractory chronic graft-vs.-host-disease [3]

Angelo Michele Carella, Samantha Biasco, Sandro Nati, Angela Congiu, Enrica Lerma

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)623-624
Number of pages2
JournalLeukemia and Lymphoma
Issue number3
Publication statusPublished - Mar 2007

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this